GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cyanotech Corp (OTCPK:CYAN) » Definitions » ROE %

Cyanotech (Cyanotech) ROE % : -28.90% (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is Cyanotech ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Cyanotech's annualized net income for the quarter that ended in Dec. 2023 was $-4.08 Mil. Cyanotech's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $14.12 Mil. Therefore, Cyanotech's annualized ROE % for the quarter that ended in Dec. 2023 was -28.90%.

The historical rank and industry rank for Cyanotech's ROE % or its related term are showing as below:

CYAN' s ROE % Range Over the Past 10 Years
Min: -29.83   Med: -1.09   Max: 11.79
Current: -29.83

During the past 13 years, Cyanotech's highest ROE % was 11.79%. The lowest was -29.83%. And the median was -1.09%.

CYAN's ROE % is ranked worse than
91.81% of 1820 companies
in the Consumer Packaged Goods industry
Industry Median: 6.405 vs CYAN: -29.83

Cyanotech ROE % Historical Data

The historical data trend for Cyanotech's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyanotech ROE % Chart

Cyanotech Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.78 2.52 5.59 11.79 -19.20

Cyanotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.28 -33.57 -34.89 -21.65 -28.90

Competitive Comparison of Cyanotech's ROE %

For the Packaged Foods subindustry, Cyanotech's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyanotech's ROE % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Cyanotech's ROE % distribution charts can be found below:

* The bar in red indicates where Cyanotech's ROE % falls into.



Cyanotech ROE % Calculation

Cyanotech's annualized ROE % for the fiscal year that ended in Mar. 2023 is calculated as

ROE %=Net Income (A: Mar. 2023 )/( (Total Stockholders Equity (A: Mar. 2022 )+Total Stockholders Equity (A: Mar. 2023 ))/ count )
=-3.44/( (19.487+16.347)/ 2 )
=-3.44/17.917
=-19.20 %

Cyanotech's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-4.08/( (14.407+13.833)/ 2 )
=-4.08/14.12
=-28.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Cyanotech  (OTCPK:CYAN) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-4.08/14.12
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-4.08 / 22.328)*(22.328 / 27.668)*(27.668 / 14.12)
=Net Margin %*Asset Turnover*Equity Multiplier
=-18.27 %*0.807*1.9595
=ROA %*Equity Multiplier
=-14.74 %*1.9595
=-28.90 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-4.08/14.12
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-4.08 / -4.08) * (-4.08 / -3.392) * (-3.392 / 22.328) * (22.328 / 27.668) * (27.668 / 14.12)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 1.2028 * -15.19 % * 0.807 * 1.9595
=-28.90 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Cyanotech ROE % Related Terms

Thank you for viewing the detailed overview of Cyanotech's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyanotech (Cyanotech) Business Description

Traded in Other Exchanges
N/A
Address
73-4460 Queen Kaahumanu Highway, Suite 102, Kailua-Kona, HI, USA, 96740
Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The company's products include BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. BioAstin Hawaiian Astaxanthin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health. It derives maximum revenue from the Packaged product and geographically from the United States.
Executives
Kakuk Collette Nicole officer: Chief Strategic Comml Officer 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Michael A / Davis director, 10 percent owner 1621 JUANITA LANE, TIBURON CA 94920
Angela May Mcelwee director 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Charles Jason Hartmann officer: VP, Sales & Marketing 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Glenn Jensen officer: VP-Operations 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA-KONA HI 96740
Jennifer M. Johansen officer: VP of Quality 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA HI 96740
Walter Bennett Menzel director 45 MOUNT TIBURON ROAD, TIBURON CA 94920
Felicia I Ladin officer: CFO, VP Fin & Admin, Treasurer 26 CORPORATE CIRCLE, ALBANY NY 12203
Matthew Keith Custer officer: Vice President, Gen Mgr 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA HI 96740
Amy Beth Nordin officer: VP, HR, Secretary 73-4460 QUEEN KAAHUMANU HWY. SUITE 102, KAILUA-KONA HI 96740
Brian Brett Orlopp officer: CFO, VP, Treasurer, Secretary 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA CA 96740
Gerald J Watts officer: COO 2530 RED HILL AVE, SANTA ANA CA 92705
Mawae Morton officer: President 7473 MAKA'A STREET, HONOLULU HI 96825
Nancy E Katz director CALYPTE BIOMEDICAL CORP, 1265 HARBOR BAY PKWY, ALAHEDA CA 94502
David M Mulder director 21771 CALATRAVA, MISSION VIEJO CA 92692